Chengdu Easton Biopharmaceuticals Co., Ltd. (SHA:688513)
China · Delayed Price · Currency is CNY 55.87
+4.37 (8.49%)
Jul 10, 2026, 3:00 PM CST
SHA:688513 Market Cap
SHA:688513 has a market cap or net worth of 9.74 billion as of July 10, 2026. Its market cap has increased by 25.04% in one year.
Market Cap
9.74B
Enterprise Value
8.30B
Revenue
1.35B
Ranking
n/a
PE Ratio
35.35
Stock Price
55.87
Market Cap Chart
Since September 2, 2020, SHA:688513's market cap has increased from 8.97B to 9.74B, an increase of 8.56%. That is a compound annual growth rate of 1.41%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 10, 2026 | 9.74B | -9.23% |
| Dec 31, 2025 | 10.73B | 104.34% |
| Dec 31, 2024 | 5.25B | -31.43% |
| Dec 29, 2023 | 7.66B | 4.83% |
| Dec 30, 2022 | 7.31B | 31.12% |
| Dec 31, 2021 | 5.57B | -2.50% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Sep 2, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| GemPharmatech | 9.91B |
| Hualan Biological Vaccine | 9.77B |
| Jiangsu Sinopep-Allsino Biopharmaceutical | 8.94B |
| Nanjing Vazyme Biotech | 8.92B |
| Chongqing Genrix Biopharmaceutical | 8.77B |
| Pacific Shuanglin Bio-pharmacy | 8.57B |
| Sino Biological,Inc. | 8.52B |
| Aurisco Pharmaceutical | 8.15B |